Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Achieve Life Sciences Inc (ACHV).
Achieve Life Sciences, Inc. has initiated a Registered Direct Offering and concurrent Private Placement to sell over 13 million shares and warrants, aiming to raise approximately $56.2 million in net proceeds. These funds are earmarked for the clinical development of cytisinicline, including the ORCA-OL clinical trial, and other corporate purposes. The offering is supported by a shelf registration statement and prospectus, with additional potential proceeds of $64.2 million if all Private Placement Warrants are exercised, potentially funding the company’s operations into 2026.
See more data about ACHV stock on TipRanks’ Stock Analysis page.